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Abstract
Recent evidence suggests that many complex diseases are caused by genetic variations that play regulatory roles
in controlling gene expression. Most genetic studies focus on nonsynonymous variations that can alter the amino
acid composition of a protein and are therefore believed to have the highest impact on phenotype. Synonymous
variations, however, can also play important roles in disease pathogenesis by regulating pre-mRNA processing and
translational control. In this study, we systematically survey the effects of single-nucleotide variations (SNVs) on
binding affinity of RNA-binding proteins (RBPs). Among the 10,113 synonymous SNVs identified in 697 individuals
in the 1,000 Genomes Project and distributed by Genetic Analysis Workshop 17 (GAW17), we identified 182
variations located in alternatively spliced exons that can significantly change the binding affinity of nine RBPs
whose binding preferences on 7-mer RNA sequences were previously reported. We found that the minor allele
frequencies of these variations are similar to those of nonsynonymous SNVs, suggesting that they are in fact
functional. We propose a workflow to identify phenotype-associated regulatory SNVs that might affect alternative
splicing from exome-sequencing-derived genetic variations. Based on the affecting SNVs on the quantitative traits
simulated in GAW17, we further identified two and four functional SNVs that are predicted to be involved in
alternative splicing regulation in traits Q1 and Q2, respectively.
Background
Alternative splicing is an important level of gene regula-
tion and greatly contributes to proteome diversity [1]. In
humans, more than 90% of genes encode multiple protein
isoforms [2], and many diseases are caused by the disregu-
lation of splicing patterns [3,4]. In eukaryotic cells, splicing
patterns are tightly regulated in a temporospatial manner
through a set of RNA-binding proteins (RBPs) that bind to
cis-acting sites on the precursor mRNA (pre-mRNA).
With the advent of microarray and next-generation
sequencing technology, the RNA-binding consensus
sequences of several RBPs have recently been identified
[5-8].
Nonsynonymous single-nucleotide polymorphisms
(SNPs) alter the amino acid composition of a protein;
their effects on protein functions can be predicted by
many bioinformatics tools, including SIFT [9], PolyPhen
[10], SNPs3D [11], and MAPP [12]. Nonsynonymous
SNPs contribute to the etiology of many diseases [13].
Recent studies, however, suggest that synonymous SNPs
in exons are also functionally important [14]. These varia-
tions frequently affect the binding of splicing regulatory
factors (SRFs) and potentially result in abnormal pre-
mRNA splicing patterns. We have previously reported a
transcriptome-wide profiling of SFRS1 protein, a highly
conserved, essential pre-mRNA splicing factor with dual
functions in constitutive and alternative splicing [7]. A
search for the SFRS1 consensus motif within the Human
Gene Mutation Database identified 181 mutations in 82
different genes that disrupt the predicted SFRS1 binding
sites [7].
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systematically characterize the potential capability of sin-
gle-nucleotide variations (SNVs) to regulate alternative
splicing. Focusing on the exonic SNVs identified in each
of the seven populations in the 1000 Genomes Project,
we found that the minor allele frequencies (MAFs) for
the synonymous SNVs residing in alternatively spliced
exons and potentially disrupting the binding of RBPs are
more comparable to nonsynonymous SNVs than to other
SNVs, suggesting that they are under similar selection
pressure. This result suggests the importance of regula-
tory SNVs that are associated with certain diseases or
phenotypes and the importance of integrating biological
annotation into genetic association studies. Furthermore,
from the SNVs that are simulated to be associated with
the phenotypes distributed by Genetic Analysis Work-
shop 17 (GAW17) [15], we identified two and four regu-
latory candidates for phenotypes Q1 and Q2, respectively.
Methods
Data
Genotypes of SNVs for 697 individuals from seven popula-
tions (CEPH [European-descent population from Utah],
Denver Chinese, Han Chinese, Japanese, Luhya, Tuscan,
and Yoruba) were derived from the sequence alignment
files created in the 1000 Genomes Project and distributed
by GAW17. We considered 24,487 exonic SNVs (both
synonymous and nonsynonymous) within 3,205 autosomal
genes. For phenotypes, the GAW17 committee carried out
200 replicate simulations on traits Q1 and Q2 and disease
liability for 697 individuals; the simulations were based on
an answer sheet of associated SNVs for each trait [15].
Assessing the capability of a genetic variation to change
the binding affinity of an RNA-binding protein
As a proof of concept, we focus our analysis on nine RBPs
whose binding affinity has been characterized using an in
vitro assay called RNAcompete [8]. Using a customized
microarray that contains all the potential 7-base and 8-
base sequences and a single binding reaction, this technol-
ogy determines the relative preferences of RBPs for short
RNA sequences. For each of the nine RBPs being studied
(HuR, Vts1, FUSIP1, PTB, U1A, SF2/ASF, SLM2, RBM4,
and YB1), a preference score is provided for every possible
RNA 7-mer, indicating the level of binding affinity of the
specific RBP-7mer RNA pair [8].
To evaluate the potential of a SNV to alter the binding
affinity of an RBP, for each RBP we first characterized the
distribution of the preference scores for the binding and
nonbinding events; a higher preference score indicates
higher binding potential. We used the mean plus 3 times
the standard deviation as the cutoff to distinguish binding
and nonbinding events. As indicated in Figure 1A,
the preference score distributions for binding and
nonbinding events form two normal-like distributions.
For each SNV, we retrieved the highest preference score
for the seven possible 7-mers that contain the variation
and calculated the binding preference scores for the
major allele and minor allele separately. We then used
the following strategy to calculate the capability of one
SNV to change the binding affinity of an RBP:
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where PSmin and PSmaj are the RBP’s preference score for
the minor allele and the major allele, respectively; b and n
denote score distributions for the binding and nonbinding
events, respectively; and SbP S , min is the area to the right of
the preference score on the minor allele (PSmin) under the
distribution indicating binding events (b). A positive or
negative AC value indicates that the minor allele will cause
a gain or loss of binding affinity, respectively.
Alternative splicing events
We used the AltEvent track in the UCSC (University of
California, Santa Cruz) Genome Browser to identify the
SNVs residing in the exons that can be alternatively
spliced [16]. This track documents various types of alter-
native splicing that result in more than one gene isoform.
We consider here the SNVs labeled to be associated with
alternatively spliced exons by the UCSC Table Browser.
These variations are more likely to be associated with the
splicing regulation.
GAW17 data analysis
We calculated the capability of changing the binding affi-
nity of each RBP for all 24,487 exonic SNVs, based on the
AC score (Eq. (1)), which is defined as the logarithmic
ratio of the binding likelihood of the minor and major
alleles. A more extreme positive or negative AC value indi-
cates a higher possibility of altering an RBP’s binding affi-
nity (gain or loss of the binding). For each RBP, the AC
values for all the exonic SNVs follow a normal-like distri-
bution; one example, for SFRS1 (or SF2), is shown in
Figure 1B. We consider the outliers, the SNVs with AC
values larger than the mean plus 3 times the standard
deviation or less than the mean minus 3 times the stan-
dard deviation, as candidates that may change the binding
affinity of the RBP.
Results and discussion
Many synonymous variations potentially change the
binding of RBPs
To illustrate the regulatory role of SNVs, we focused
our analysis on 10,113 synonymous SNVs, of which
1,851 candidates potentially affect the binding of at least
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tions potentially affect the binding of more than one
RBP: 173 variations affect bindings of 2 RBPs and 10
variations affect 3 RBPs. We clustered these 183
synonymous SNVs based on their AC values. Clearly,
some of the SNVs can potentially cause the gain or loss
of the binding of two RBPs. For instance, Vts1 and
RBM4 share 32 SNVs in the heat map (Figure 2A).
Figure 1 Computational strategy (A) Assessing the capability of a SNV to change the binding affinity of an RBP. (B) Distribution of AC values
for SF2.
Teng et al. BMC Proceedings 2011, 5(Suppl 9):S40
http://www.biomedcentral.com/1753-6561/5/S9/S40
Page 3 of 7Similar relationships can be found between RBM4 and
SF2, between FUSIP1 and SLM2, and between PTB and
HuR. Interestingly, some SNVs (e.g., the SF2-FUSIP1
pair) can cause antagonistic effects on the binding of
two RBPs: the loss of the binding of one RBP and the
gain of another one. For the PTB-HuR pair, some varia-
tions can cause the loss or gain of binding to both
RBPs, whereas others can cause the gain of PTB with
the loss of HuR. The relationships between binding
changes to the nine RBPs are shown in the principal
components analysis (PCA) biplot [17] (Figure 2B). In
this figure each dot represents one of the 183 synon-
ymous SNVs in the first three principal components,
and the nine lines represent the nine RBPs, using their
weights for the components. Biplots provide one way to
use the correspondence between the SNV-like and RBP-
like patterns revealed by PCA to identify groups of RBPs
that have binding that is characteristic of a group of var-
iations. The angles between two RBPs indicate the simi-
larity of the effect of variations on their binding affinity.
For instance, both the Vts1-RBM4 and the HuR-PTB
pairs show similar directionality, whereas the line for
SF2 is almost opposite to the direction of FUSIP1.
Synonymous variations that potentially regulate
alternative splicing show lower minor allele frequency
To characterize the disease relevance of predicted synon-
ymous SNVs that potentially affect RBP binding, we
further divided all the synonymous SNVs into four (nono-
verlapping) categories: (1) synonymous SNVs affecting
RBP binding but not located within alternatively spliced
exons (SS+RBP−Alt), (2) synonymous SNVs located within
alternatively spliced exons but not affecting RBP binding
(SS+Alt−RBP), (3) synonymous SNVs not only affecting
RBP binding but also located within alternatively spliced
exons (SS+RBP+Alt), and (4) synonymous SNVs located
outside alternatively spliced exons and not affecting any
RBP binding (SS−RBP−Alt). We examined the MAFs of
the SNVs in the different categories based on all 697 indi-
viduals distributed by GAW17. We found that the average
MAFs for the category SS+RBP+Alt are similar to the
ones for the nonsynonymous SNVs in all the populations
Figure 2 Relationships between synonymous variations and their effects on the binding of RBPs (A) Hierarchical clustering of RBPs and
183 synonymous variations that can potentially affect binding of more than one RBP, based on their AC values (Eq. (1)); red and blue indicate
potential gain and loss of binding in the minor alleles. (B) Principal components analysis (PCA) biplot with variations plotted against the top
three principal components; nine RBPs show their similarity or dissimilarity with respect to the effects of variations on their binding affinity.
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are markedly higher (Figure 3). Student’s t test was used
to quantitatively measure the significance of MAF differ-
ences between different categories; p-values are labeled in
Figure 3. In addition, the MAFs show that the trends in
each of the seven individual populations are similar to
those in all the individuals (data not shown). This result
indicates that the synonymous SNVs within alternatively
spliced exons that affect RBP binding are under similar
selection as the nonsynonymous SNVs and may contribute
to the disease by influencing the splicing patterns. How-
ever, it should be noted that experimental validation is
required to truly identify the functions of these SNV can-
didates (SS+RBP+Alt). We have also examined the MAFs
of the nonsynonymous variations that potentially affect
alternative splicing. We have not seen significant differ-
ences compared to other nonsynonymous variations (data
not shown). This suggests that amino-acid-changing SNVs
are under similar selection pressure regardless of their
splicing regulating potentials.
Prioritizing phenotype-associated variations that regulate
alternative splicing
Based on our observations, we propose a workflow to
prioritize variations identified in the exome sequencing
(Figure 4). First, those SNVs associated with the phe-
notype can be selected on the basis of a statistical pro-
cedure. Then, to prioritize these, we first predict
whether the identified single-nucleotide variation will
affect the binding of RBPs using the strategy presented
in the Methods section. Among the SNVs that affect
RBP binding, we select those located within a known
alternatively spliced exon, using the AltEvent track in
the UCSC Genome Browser or other bioinformatics
tool. The variations that meet all criteria are candi-
dates for functional SNVs that potentially affect the
phenotype.
Distributed by GAW17, each of traits Q1, Q2, and dis-
ease liability are simulated to be affected by a particular
set of nonsynonymous SNVs [15]. We further checked
whether these SNVs can also potentially regulate alter-
native splicing by affecting the binding of RNA-binding
proteins, using the outlined workflow. We found that
two and four SNVs were involved in alternative splicing
in traits Q1 and Q2, respectively (Table 1); no SNVs
were found for disease liability. This result suggests that
the nonsynonymous SNVs may affect the traits both by
causing amino acid substitutions and by regulating spli-
cing patterns. Without loss of generalizability, synon-
ymous regulatory SNVs for phenotypes can also be
Figure 3 Comparisons of MAFs among different categories of SNVs according to 697 individuals.
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obtain a set of associated candidates.
Conclusions
We present a strategy to prioritize synonymous SNVs
based on their likely capacity to change the binding affi-
nity of an RBP and thereby affect pre-RNA splicing.
Synonymous variations within alternatively spliced
exons that affect RBP binding appear to be under simi-
lar selection pressure as nonsynonymous SNVs and
therefore are candidates for functional SNVs affecting
the phenotype. Synonymous SNVs that are outside the
AltEvent or that do not affect RBP binding are under
less selection pressure and therefore are considered less
likely to be functional. We also show that some RBPs
may have antagonistic relations when binding to
synonymous variations, whereas others share the com-
mon consequence of gain or loss of binding. Trait-speci-
f i cr e g u l a t o r yS N V si n d i c a t et h a ts o m en o n s y n o n y m o u s
SNVs not only result in amino acid substitution but also
regulate alternative splicing.
Our proposed workflow provides an applicable way to
identify phenotype-associated variations involved in alter-
native splicing. It should be noted that both nonsynon-
ymous and synonymous variations that affect alternative
splicing can be identified by using this workflow. The
results of this analysis will lead to novel hypotheses for
investigating the mechanisms of disease-causing mutations.
T h en i n eR B P sa n a l y z e di nt h i ss t u d ya r ep r o p e r l y
assessed for their binding preferences on RNA 7-mers
[8]. Without losing generalizability, the same strategy
can be applied to other RBPs or to microRNA binding
sites. With the technological advent of next-generation
sequencing and the application of CLIP (crosslinking
immunoprecipitation)-seq or RIP-seq technologies
[7,18,19], binding affinities of more RBPs will be avail-
able. This will provide greater opportunity to under-
stand the genetic mechanisms of disease.
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